Jennifer Cote - Mar 5, 2024 Form 4 Insider Report for HARVARD BIOSCIENCE INC (HBIO)

Signature
/s/ David Sirois, by power of attorney
Stock symbol
HBIO
Transactions as of
Mar 5, 2024
Transactions value $
-$40,771
Form type
4
Date filed
3/7/2024, 04:04 PM
Previous filing
Jan 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HBIO Common Stock Award $0 +35.8K +33.44% $0.00 143K Mar 5, 2024 Direct F2
transaction HBIO Common Stock Award $0 +35.8K +25.06% $0.00 179K Mar 5, 2024 Direct F3
transaction HBIO Common Stock Tax liability -$40.8K -9.92K -5.55% $4.11 169K Mar 6, 2024 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Company solely to cover tax obligations upon the vesting of 29,880 restricted stock units ("RSUs").
F2 Represents an award of RSUs that will vest in three equal installments on March 19, 2025, 2026, and 2027.
F3 The number of RSUs represents the target number of RSUs that may be earned based on achievement by the Company of certain performance criteria. The actual number of RSUs awarded may vary between 0% and 150% of the target, depending on the Company's performance. The performance period will end on December 31, 2026.
F4 Includes (a) the awards described in footnotes (2) and (3) above, (b) 17,928 RSUs that will vest in two equal installments on December 29, 2024 and 2025, (c) 11,171 RSUs that will vest on December 29, 2024, (d) 25,862 RSUs with performance based vesting conditions tied to relative total shareholder return and (e) 42,177 shares of common stock beneficially owned by the Reporting Person.